SCHEMBL13257587

SCHEMBL13257587

CCSc1nc2cc[nH]c2c(=O)n1-c1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 4/20 0.53
NPSR1 Q6W5P4 1/20 0.41
PDE7B Q9NP56 1/20 0.39
TGM2 P21980 1/20 0.39
ALDH1A1 P00352 3/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
GAA P10253 2/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 5/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
PTBP1 P26599 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13257621 0.91 APLNR (0.48) PDE7AESR1ESR2TSHRLMNA
SCHEMBL13258410 0.87 ALDH1A1 (0.39) PDE7APDE7BTGM2ALDH1A1LMNA
SCHEMBL13257458 0.85 PDE7A (0.42) PDE7APDE7BTGM2ALDH1A1LMNA
SCHEMBL13258405 0.84 PDE7A (0.38) PDE7AALDH1A1GAATSHRLMNA
SCHEMBL13257579 0.84 PDE7A (0.38) PDE7AALDH1A1GAALMNAMAPT
SCHEMBL13258372 0.84 ALDH1A1 (0.37) PDE7APDE7BTGM2ALDH1A1LMNA
SCHEMBL13257642 0.81 PDE7A (0.51) PDE7ANPSR1TGM2ALDH1A1GAA
SCHEMBL13266433 0.81 TSHR (0.45) PDE7ANPSR1ALDH1A1GAATSHR
SCHEMBL13258409 0.81 LMNA (0.37) PDE7APDE7BTGM2ALDH1A1GAA
SCHEMBL2561473 0.80 FADS1 (0.49) PDE7ANPSR1ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010087467-A1 DELTA-5-DESATURASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed